The performance of levonorgestrel rod and Norplant® contraceptive implants: A 5 year randomized study

Human Reproduction

Volumn 13, Issue 12, 1998, Pages 3371-3378

  Sivin, Irving ^a   Campodonico, Italo ^b   Kiriwat, Orawan ^c   Holma, Pentti ^d   Diaz, Soledad ^e   Wan, Livia ^f   Biswas, Arijit ^g   Viegas, Osborn ^g   Abdalla, Kamal El Din ^h   Anant, Manee Piya ^c   Pavez, Margarita ^e   Stern, Janet ^a  

^a POPULATION COUNCIL   (United States)

^b APROFA   (Chile)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Department of Medicine   (Finland)

^e Instituto Chileno de Medicina Reproductiva   (Chile)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^h MINIA UNIVERSITY   (Egypt)

Author keywords

Contraception; Levonorgestrel; Randomized studies; Rod implants

Indexed keywords

CONTRACEPTIVE AGENT; LEVONORGESTREL; UNCLASSIFIED DRUG;

ACNE; ADULT; AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MENSTRUATION DISORDER; MULTICENTER STUDY; NORMAL HUMAN; PARITY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN;

EID: 0032442789     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.12.3371     Document Type: Article

References (48)

1. Affandi, B., Santoso, S.S.I., Djajadilaga, et al. (1987) Pregnancy after removal of NORPLANT®. Contraception, 36, 203-209.
2. Archer, D.F., Philput, C.A. and Weber, M.E. (1996) Management of irregular uterine bleeding and spotting associated with Norplant®. Hum. Reprod., 11 (Suppl. 2), 24-30.
3. Berenson, A.B., Wiemann, C.M., Rickert, V.I. and McCombs, S.L. (1997) Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use. Am. J. Obstet. Gynecol., 176, 586-592.
4. Biswas, A., Leong, W.P., Ratnam, S.S. and Viegas, O.A.C. (1996) Menstrual bleeding patterns in Norplant 2 implant users. Contraception, 54, 91-95.
5. Blumenthal, P.D., Wilson, L.E., Remsburg, R.E. et al. (1994) Contraceptive outcomes among postpartum and postabortal adolescents. Contraception, 50, 451-460.
6. Bookasemanti, W, Reinprayoon, D., Pruksanonda, K. et al. (1996) the effect of transdermal estradiol on bleeding pattern, hormone profile and sex steroid receptor distribution in the endometrium of Norplant users. Hum. Reprod., 11 (Suppl. 2), 115-123.
7. Buckshee, K., Chatterjee, P., Dhall, G.I. et al./Indian Council of Medical Research Task Force on Hormonal Contraception (1993) Phase III Clinical Trial with Norplant II (two covered rods). Report on five years of use. Contraception, 48, 120-132.
8. Crosby, U.D., Schwarz, B.E., Gluck, K.L. and Heartwell, S.F. (1993) Preliminary report of NORPLANT implant insertions in a large urban family planning program. Contraception, 48, 359-366.
9. Cullins, V.E., Blumenthal, P.D., Remsburg, R.E. and Huggins, G.R. (1993) Preliminary experience with NORPLANT in an inner city population. Contraception, 47, 193-204.
10. Dinerman, L.M., Wilson, M.D., Duggan, A.K. and Joffe, A. (1995) Outcomes of adolescents using levonorgestrel implants vs oral contraceptives or other contraceptive methods. Arch. Pediat. Adolesc. Med., 149, 967-972.
11. Dugoff, L., Jones, O.W. III, Allen-Davis, J. et al. (1995) Assessing the acceptability of NORPLANT contraceptive in four patient populations. Contraception, 52, 45-49.
12. Fisher, A., Prihartono, J., Tuladhar, J. and Hoesni, R.H.M. (1997) An assessment of NORPLANT® removal in Indonesia. Stud. Fam. Plann., 28, 308-316.
13. Frank, M.L., Poindexter, A.N. III, Cornin, L.M. et al. (1993) One year experience with subdermal contraceptive implants in the United States. Contraception, 48, 229-249.
14. Franks, A.L., Beral, V., Cates, W Jr, and Hogue, C.J.R. (1990) Contraception and ectopic pregnancy risk. Am. Obstet. Gynecol., 163, 1120-1123.
15. Fraser, I.S., Tiitinen, A., Affandi, B. et al. (1998) Norplant Consensus Statement. Contraception, 57, 1-9.
16. Gerber, S., Westhoff, C., Lopez, M. and Gordon, L. (1994) Use of Norplant implants in a New York City clinic population. Contraception, 49, 557-564.
17. Graves, E.J. (1992) Detailed diagnoses and procedures, National Hospital Discharge Survey, 1990. Vital Health Stat., 13, Table 1.
18. Gu, S.J., Du, M.K., Zhang, L.D. et al. (1994) A five-year evaluation of NORPLANT® II implants in China. Contraception, 50, 27-34.
19. Haugen, M.M., Evans, C.B. and Kim, M.H. (1996) Patient satisfaction with a levonorgestrel-releasing contraceptive implant: Reasons for and patterns of removal. J. Reprod, Med., 41, 849-854.
20. International Committee for Contraception Research (ICCR) (1978) Contraception with long-acting subdermal implants I. An effective and acceptable modality in international clinical trials. Contraception, 18, 315-333.
21. Kozlowski, K.J., Rickert, V.I., Hendon, A. and Davis, P. (1995) Adolescents and NORPLANT: Preliminary findings of side effects. J. Adol. Health, 16, 373-378.
22. Marangoni, P., Cartegena, S., Alvarado, J. et al. (1983) NORPLANT ® implants and the TCu 200 IUD: a comparative study in Ecuador. Stud. Fam. Plann., 14, 177-180.
23. Meirik, O. (1997) Presentation on NORPLANT Postmarketing Surveillance at the Institute of Medicine, Washington DC, April 7, 1997
24. Meng, F. and Gu, S.J. (1996) Menstrual bleeding patterns in Chinese women using the NORPLANT subdermal implant. Hum. Reprod., 11 (Suppl. 2), 14-19.
25. Peterson, H., Xia, Z., Hughes, J., et al. (1996) The risk of pregnancy after tubal sterilization. Am. J. Obstet. Gynecol., 174, 1161-1170.
26. Polaneczky, M., Slap, G., Forke, C. et al. (1994) The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N. Engl. J. Med., 331, 1201-1206.
27. Ricketts, S.A. (1996) Repeat fertility and contraceptive implant use among Medicaid recipients in Colorado. Fam. Plann. Persp., 28, 278-284.
28. Rosenthal, S.L., Biro, F.M., Kollar, L.M. et al. (1995) Experience with side effects and health risks associated with NORPLANT implant use in adolescents. Contraception, 52, 283-285.
29. Shaaban, M.M., Salah, M., Zarzour, A. and Abdullah, S.A. (1983) A prospective study of NORPLANT® implants and the Tcu 380Ag IUD in Assiut, Egypt. Stud. Fam. Plann., 14, 163-169.
30. Shoupe, D., Mishell, D.R. Jr., Bopp, B.L. and Fielding, M. (1991) The significance bleeding patterns in NORPLANT implant users. Obstet. Gynecol., 77, 256-260.
31. Singh, K., Viegas, O.A.C., Fong, Y.F. and Ratnam, S.S. (1992) Acceptability of NORPLANT® 2 as a method of family planning. Contraception, 45, 453-461.
32. Sivin, I. (1988) International Experience with NORPLANT® and NORPLANT 2 contraceptives. Stud. Fam. Plann., 19, 81-94.
33. Sivin, I. (1991a) Alternative estimates of ectopic pregnancy during contraception. Am. J. Obstet. Gynecol., 165, 1899-1900.
34. Sivin, I. (1991b) Age and dose dependent risks of ectopic pregnancy. Obstet. Gynecol., 78, 291-298.
35. Sivin, I. (1994) Contraception with NORPLANT® implants. Hum. Reprod., 9, 1818-1826.
36. Sivin, I. and Brown, G. (1983) The introduction of NORPLANT implants. Stud. Fam. Plann., 14, 192-193.
37. Sivin, I., Robertson, D.N., Stern, J. et al. (1980) Norplant: Reversible implant contraception. Stud. Fam. Plann., 11, 227-235.
38. Sivin, I., Stern, J., Diaz, S. et al. (1992) Rates and outcomes of planned pregnancy after use of NORPLANT®, NORPLANT® II rods, or levonorgestrel-releasing or copper TCu 380 Ag intrauterine contraceptive devices. Am. J. Obstet. Gynecol., 166, 1208-1213.
39. Sivin, I., Lahteenmaki, P., Ranta, S. et al. (1997a) Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants. Contraception, 55, 81-85.
40. Sivin, I., Viegas, O.A.C., Campodonico, I. et al. (1997b) Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with NORPLANT implants as controls: Contraception, 55, 73-80.
41. Sivin, I., Mishell, D.R. Jr., Darney, P. et al. (1998) Levonorgestrel capsule implants in the United States. Obstet. Gynecol., 92
42. Skjeldestad, F.E. (1997) How effectively do copper intrauterine devices prevent ectopic pregnancy? Acta Obstet. Gynecol. Scand., 76, 684-690
43. Trussell, J., Leveque, J.A., Koenig, J.D. et al. (1995) The economic value of contraception: a comparison of 15 methods. Am. J. Public Health, 85, 494-503.
44. U.S. Dept. of Health and Human Services (1994) Health United States DHHS Pub. No. PHS 95-1232. Library of Congress cat. No. 76-641496.
45. Vekemans, M., Delvigne, A. and Paesmans, M. (1997) Continuation rates with a levonorgestrel-releasing contraceptive implant (Norplant®). Contraception, 56, 291-299.
46. Witjaksono, J., Bookasemanti, W., Archer, D.F. et al. (1996) Oestrogen treatment for increased bleeding in Norplant users: Preliminary results. Hum. Reprod., 11 (Suppl. 2), 109-114.
47. WHO Collaborating Centre for International Drug Monitoring, Uppsala (1993) WHO Adverse Reaction Dictionary (WHOART). WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden.
48. Zhang, Z.-M., Weng, L.-J., Zhang, Z.-Y. et al. (1994) An epidemiological study of the relationship of ectopic pregnancy and the use of contraceptives in Beijing: the incidence of ectopic pregnancy in the Beijing area. Contraception, 50, 253-262.